Back to the main directory
EarningsReview / Equity
- Formycon - H121 update: Future markets take shape by Edison Investment Research
- MUNICH RE: AVANCE DE RDOS. 3T’21 (ANÁLISIS BANCO SABADELL) by Sabadell
- Q321 sales and 15 questions for management by BNP Paribas Exane
- ODDO : Preview T3 2021: se laisser porter par le cycle de digitalisation post COVID by Oddo BHF
- Where''s the wow factor? by BNP Paribas Exane
- Hindustan Unilever Ltd (HUVR IN) by HSBC
- Norske Skog (Buy, TP: NOK46.00) - On the road to margin recovery by DnB Markets
- Coloplast (Sell, TP: DKK900.00) - by DnB Markets
- Star Bulk (Buy, TP: USD33.00) - Promising near-term spot exposure by DnB Markets
- Carlsberg (Hold, TP: DKK1175.00) - Cost inflation remains an overhang by DnB Markets
- Skanska (Hold, TP: SEK220.00) - Q3e disappointment ahead by DnB Markets
- Metso Outotec (Buy, TP: EUR11.00) - Focus on orders and operations by DnB Markets
- Norway Royal Salmon (Buy, TP: NOK225.00) - ‘Strategic dialogue’ in focus by DnB Markets
- Genmab (Hold, TP: DKK2900.00) - Strong Darzalex sales in Q3 by DnB Markets
- China State Const Intl (3311 HK) by HSBC
- Itaú BBA on América Móvil: Neutral 3Q21 Results, as Expected by Itau
- On the (virtual) road with Exane BNP Paribas by BNP Paribas Exane
- Biff, bash, bosh by BNP Paribas Exane
- Beijer Ref - Hold: Short-term headwinds, long-term tailwinds by Nordea
- Genmab - Darzalex sales momentum continues by Danske Bank Equity Research
- Tele2 - Hold: Premium valuation justified but restrictive by Nordea
- ODDO : Hôtellerie Europe : après une reprise estivale forte, le mois de septembre est plus mitigé by Oddo BHF
- ODDO : Hotels in Europe: after a strong recovery in the summer, a more mixed September by Oddo BHF
- Santander CIB: Vinci: 3Q21: Net Debt Reduced by €1.7bn QoQ by Santander
- INVEST SECURITIES - KERING : Une marque Gucci décidément très cyclique - NEUTRE, OC 658€ (vs 719€) by Invest Securities